The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Genomic Health; Roche/Genentech; Sanofi
Consulting or Advisory Role - Amgen; Genomic Health; Roche/Genentech; Sanofi
Final analysis of WSG-ADAPT HER2+/HR- trial: Efficacy, safety, and predictive markers for 12-weeks of neoadjuvant dual blockade with trastuzumab + pertuzumab ± weekly paclitaxel in HER2+/HR- early breast cancer (EBC).
 
Ulrike Nitz
Honoraria - Agendia; Amgen; Celgene; Genomic Health; Roche/Genentech; Teva
Consulting or Advisory Role - Genomic Health; Roche/Genentech
Speakers' Bureau - Roche/Genentech; Teva
Research Funding - Amgen (Inst); Celgene (Inst); Genomic Health (Inst); Roche/Genentech (Inst); Teva (Inst)
Expert Testimony - Genomic Health
Travel, Accommodations, Expenses - Amgen; Roche/Genentech
 
Oleg Gluz
Honoraria - Amgen; Genomic Health; Roche/Genentech
Consulting or Advisory Role - Genomic Health; NanoString Technologies; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Roche/Genentech
 
Matthias Christgen
No Relationships to Disclose
 
Eva-Maria Grischke
No Relationships to Disclose
 
Doris Augustin
No Relationships to Disclose
 
Sherko Kümmel
Honoraria - Amgen; Celgene; Genomic Health; Novartis; Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene; Roche/Genentech
 
Michael Wilhelm Braun
No Relationships to Disclose
 
Jochem Potenberg
No Relationships to Disclose
 
Andreas Kohls
No Relationships to Disclose
 
Katja Krauss
No Relationships to Disclose
 
Andrea Stefek
No Relationships to Disclose
 
Claudia Schumacher
No Relationships to Disclose
 
Helmut Forstbauer
No Relationships to Disclose
 
Toralf Reimer
No Relationships to Disclose
 
Hans Holger Fischer
No Relationships to Disclose
 
Cornelia Liedtke
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; GlaxoSmithKline; PharmaMar; Roche
Consulting or Advisory Role - Genomic Health; Novartis; Pierre Fabre; Roche; Teva
Speakers' Bureau - Genomic Health
Research Funding - Boehringer Ingelheim; Eisai; Novartis; Roche
Travel, Accommodations, Expenses - Celgene; PharmaMar; Roche; Teva
 
Rachel Wuerstlein
No Relationships to Disclose
 
Hans Heinrich Kreipe
Honoraria - AstraZeneca; Boehringer Ingelheim; Genomic Health; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Genomic Health; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Genomic Health; Roche/Genentech
 
Nadia Harbeck
Honoraria - Amgen; Celgene; Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Novartis; Pfizer; Roche/Genentech; Sandoz
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)